0001722024-21-000008.txt : 20210601
0001722024-21-000008.hdr.sgml : 20210601
20210601172247
ACCESSION NUMBER: 0001722024-21-000008
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210601
FILED AS OF DATE: 20210601
DATE AS OF CHANGE: 20210601
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Alexandria Venture Investments, LLC
CENTRAL INDEX KEY: 0001722024
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40443
FILM NUMBER: 21986551
BUSINESS ADDRESS:
STREET 1: 26 NORTH EUCLID AVENUE
CITY: PASADENA
STATE: CA
ZIP: 91101
BUSINESS PHONE: 626-578-0777
MAIL ADDRESS:
STREET 1: 26 NORTH EUCLID AVENUE
CITY: PASADENA
STATE: CA
ZIP: 91101
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Singular Genomics Systems, Inc.
CENTRAL INDEX KEY: 0001850906
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 812948451
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10931 N. TORREY PINES ROAD, SUITE #100
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: (858) 333-7830
MAIL ADDRESS:
STREET 1: 10931 N. TORREY PINES ROAD, SUITE #100
CITY: LA JOLLA
STATE: CA
ZIP: 92037
4
1
wf-form4_162258255031726.xml
FORM 4
X0306
4
2021-06-01
1
0001850906
Singular Genomics Systems, Inc.
OMIC
0001722024
Alexandria Venture Investments, LLC
26 NORTH EUCLID AVENUE
PASADENA
CA
91101
0
0
1
0
Common stock
2021-06-01
4
C
0
2645985
0
A
2645985
D
Series A convertible preferred stock
2021-06-01
4
C
0
1796684
D
Common stock
1796684.0
0
D
Series B convertible preferred stock
2021-06-01
4
C
0
849301
D
Common stock
849301.0
0
D
Each share of preferred stock automatically converted into the Issuer's common stock at a ratio of 1 share of preferred stock to 1 share of common stock upon closing of the Issuer's initial public offering on May 26, 2021, for no additional consideration. The shares had no expiration date.
Not applicable.
By: ALEXANDRIA REAL ESTATE EQUITIES, INC., a Maryland corporation, managing member
By: /s/ Dean A. Shigenaga
Chief Financial Officer
2021-06-01